Liwei An

1.7k total citations · 1 hit paper
43 papers, 1.1k citations indexed

About

Liwei An is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Liwei An has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Cell Biology and 9 papers in Oncology. Recurrent topics in Liwei An's work include Hippo pathway signaling and YAP/TAZ (10 papers), DNA Repair Mechanisms (9 papers) and RNA Research and Splicing (7 papers). Liwei An is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (10 papers), DNA Repair Mechanisms (9 papers) and RNA Research and Splicing (7 papers). Liwei An collaborates with scholars based in China, United States and Hong Kong. Liwei An's co-authors include Zhaocai Zhou, Shi Jiao, Michael S.Y. Huen, Pingping Nie, Zhifa Cao, Hui Zhang, Wenjia Wang, Xulin Chen, Moubin Lin and Junyi Ju and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Liwei An

40 papers receiving 1.1k citations

Hit Papers

The alanyl-tRNA synthetase AARS1 moonlights as a lactyltr... 2024 2026 2025 2024 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liwei An China 18 553 218 198 179 171 43 1.1k
Xiaomin Lou China 20 528 1.0× 152 0.7× 201 1.0× 111 0.6× 103 0.6× 70 1.0k
Jinhai Wang China 22 681 1.2× 263 1.2× 207 1.0× 222 1.2× 158 0.9× 117 1.5k
Rolf Schwarzer Germany 14 617 1.1× 169 0.8× 145 0.7× 174 1.0× 103 0.6× 28 1.3k
Hana Kim South Korea 22 541 1.0× 301 1.4× 348 1.8× 307 1.7× 75 0.4× 82 1.7k
Tuoen Liu United States 12 852 1.5× 101 0.5× 138 0.7× 152 0.8× 184 1.1× 23 1.3k
Manoj K. Mishra United States 20 433 0.8× 319 1.5× 194 1.0× 380 2.1× 61 0.4× 47 1.3k
Guohong Liu China 23 802 1.5× 263 1.2× 363 1.8× 128 0.7× 58 0.3× 74 1.5k
Kévin Berthenet France 12 451 0.8× 145 0.7× 94 0.5× 205 1.1× 83 0.5× 15 992
Carmen C. Diaconu Romania 21 616 1.1× 366 1.7× 291 1.5× 207 1.2× 52 0.3× 103 1.4k

Countries citing papers authored by Liwei An

Since Specialization
Citations

This map shows the geographic impact of Liwei An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liwei An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liwei An more than expected).

Fields of papers citing papers by Liwei An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liwei An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liwei An. The network helps show where Liwei An may publish in the future.

Co-authorship network of co-authors of Liwei An

This figure shows the co-authorship network connecting the top 25 collaborators of Liwei An. A scholar is included among the top collaborators of Liwei An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liwei An. Liwei An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Yangwei, Zaisheng Ye, YanYan Li, et al.. (2025). Disrupting Paraspeckle Stability by Targeting WTX–NONO Phase Separation Enhances Chemotherapy Efficacy in Gastric Cancer. Cancer Research. 86(3). 693–711.
2.
Wu, Xiaojia, Qiwei Guo, Daijun Zhang, et al.. (2025). Advances in sensors technologies for composites structural health monitoring. Composite Structures. 370. 119448–119448. 3 indexed citations
3.
Tang, Yang, Ge‐Min Fang, Hui Zhang, et al.. (2024). A cofactor-induced repressive type of transcription factor condensation can be induced by synthetic peptides to suppress tumorigenesis. The EMBO Journal. 43(22). 5586–5612. 3 indexed citations
4.
Yu, Tianyu, Xiaobing Li, Yingqun Zhou, et al.. (2024). SMAD4 Limits PARP1 dependent DNA Repair to Render Pancreatic Cancer Cells Sensitive to Radiotherapy. Cell Death and Disease. 15(11). 818–818. 5 indexed citations
5.
Wang, Shilong, et al.. (2024). Modeling human gastric cancers in immunocompetent mice. Cancer Biology and Medicine. 21(7). 1–18. 4 indexed citations
6.
Han, Yi, Hui Zhang, Wenjia Wang, et al.. (2024). Epstein-Barr virus infection upregulates extracellular OLFM4 to activate YAP signaling during gastric cancer progression. Nature Communications. 15(1). 10543–10543. 8 indexed citations
7.
Ju, Junyi, Hui Zhang, Moubin Lin, et al.. (2024). The alanyl-tRNA synthetase AARS1 moonlights as a lactyltransferase to promote YAP signaling in gastric cancer. Journal of Clinical Investigation. 134(10). 148 indexed citations breakdown →
8.
Zhao, Qiudong, Yan Sang, Fei Ye, et al.. (2023). GPNMB + Gal‐3 + hepatic parenchymal cells promote immunosuppression and hepatocellular carcinogenesis. The EMBO Journal. 42(24). e114060–e114060. 8 indexed citations
9.
Cao, Zhifa, Liwei An, Yi Han, Shi Jiao, & Zhaocai Zhou. (2023). The Hippo signaling pathway in gastric cancer. Acta Biochimica et Biophysica Sinica. 55(6). 893–903. 15 indexed citations
10.
Lu, Xiaoqing, Liwei An, Guangjian Fan, et al.. (2022). EGFR signaling promotes nuclear translocation of plasma membrane protein TSPAN8 to enhance tumor progression via STAT3-mediated transcription. Cell Research. 32(4). 359–374. 54 indexed citations
11.
Meng, Yan, Qiudong Zhao, Liwei An, et al.. (2021). A TNFR2–hnRNPK Axis Promotes Primary Liver Cancer Development via Activation of YAP Signaling in Hepatic Progenitor Cells. Cancer Research. 81(11). 3036–3050. 74 indexed citations
13.
Tang, Yang, Ge‐Min Fang, Fenghua Guo, et al.. (2020). Selective Inhibition of STRN3-Containing PP2A Phosphatase Restores Hippo Tumor-Suppressor Activity in Gastric Cancer. Cancer Cell. 38(1). 115–128.e9. 94 indexed citations
14.
An, Liwei, Pingping Nie, Min Chen, et al.. (2020). MST4 kinase suppresses gastric tumorigenesis by limiting YAP activation via a non-canonical pathway. The Journal of Experimental Medicine. 217(6). 48 indexed citations
15.
An, Liwei, Megan R. Reed, Robert L. Eoff, et al.. (2019). LC8/DYNLL1 is a 53BP1 effector and regulates checkpoint activation. Nucleic Acids Research. 47(12). 6236–6249. 35 indexed citations
16.
An, Liwei, Yiyang Jiang, Ellen P.S. Man, et al.. (2017). Dual-utility NLS drives RNF169-dependent DNA damage responses. Proceedings of the National Academy of Sciences. 114(14). E2872–E2881. 53 indexed citations
17.
Liu, Li, et al.. (2016). Use of a knowledge-attitude-behaviour education programme for Chinese adults undergoing maintenance haemodialysis: Randomized controlled trial. Journal of International Medical Research. 44(3). 557–568. 74 indexed citations
19.
Wang, Weiping, et al.. (2011). Memantine attenuates the impairment of spatial learning and memory of pentylenetetrazol-kindled rats. Neurological Sciences. 32(4). 609–613. 11 indexed citations
20.
He, Wei, Chunbo Zhang, Liwei An, et al.. (2008). Rad9 plays an important role in DNA mismatch repair through physical interaction with MLH1. Nucleic Acids Research. 36(20). 6406–6417. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026